Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.96
-0.22 (-1.97%)
May 19, 2026, 1:15 PM HKT

HKG:2096 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,5121,9532,0071,658973.14
Short-Term Investments
65.531011.14964.231,210
Cash & Short-Term Investments
3,5781,9632,0182,6232,183
Cash Growth
82.29%-2.76%-23.04%20.12%-33.31%
Accounts Receivable
2,8582,7042,6452,3392,399
Other Receivables
100.5560.0650.7339.8937.37
Receivables
3,0592,7642,6952,3792,436
Inventory
673.85684.09770.14371.59290.96
Other Current Assets
79.6381.02155.1385.6169.24
Total Current Assets
7,3905,4925,6395,4584,980
Property, Plant & Equipment
2,5322,3272,1702,1391,931
Long-Term Investments
2,3521,8931,5802,2582,651
Goodwill
142.47142.47142.47172.79172.79
Other Intangible Assets
1,4431,025715.79379.959.69
Long-Term Deferred Tax Assets
520.71435.59317326.71289.97
Other Long-Term Assets
346.03183.83188.9553.7976.56
Total Assets
14,72611,60010,85410,78910,161
Accounts Payable
249.03276.06317.22335.43323.95
Accrued Expenses
999.221,0321,0451,1241,032
Short-Term Debt
1,0521,050762.431,184991.57
Current Portion of Long-Term Debt
0.70.72252.71108.37538.51
Current Portion of Leases
57.3467.5679.8558.7631.56
Current Income Taxes Payable
65.7154.3617.910.5616.16
Current Unearned Revenue
687.0628.1643.3163.3426.14
Other Current Liabilities
234.22119.7616782.41103.7
Total Current Liabilities
3,3452,7292,6862,9673,064
Long-Term Debt
7.488.25205.85--
Long-Term Leases
69.6482.42128.4155.9274.24
Long-Term Unearned Revenue
472.53400.15393.11403.35417.61
Long-Term Deferred Tax Liabilities
68.0472.7102.68115.29142.77
Other Long-Term Liabilities
1,3481,174115--
Total Liabilities
5,3114,4663,6313,6413,698
Common Stock
4,6193,1743,1743,0813,003
Retained Earnings
4,3263,4473,8373,8313,294
Comprehensive Income & Other
463.61513.29211.61219.72139.96
Total Common Equity
9,4087,1347,2237,1326,437
Minority Interest
6.72--16.0625.76
Shareholders' Equity
9,4157,1347,2237,1486,463
Total Liabilities & Equity
14,72611,60010,85410,78910,161
Total Debt
1,1871,2091,4291,5071,636
Net Cash (Debt)
2,391753.22589.081,116547.34
Net Cash Growth
217.40%27.86%-47.21%103.86%-
Net Cash Per Share
0.960.300.230.430.21
Filing Date Shares Outstanding
2,5962,4862,6172,6602,628
Total Common Shares Outstanding
2,5962,4862,6172,6602,628
Working Capital
4,0452,7642,9532,4921,916
Book Value Per Share
3.622.872.762.682.45
Tangible Book Value
7,8235,9666,3646,5796,205
Tangible Book Value Per Share
3.012.402.432.472.36
Machinery
2,9812,9622,6322,8112,528
Construction In Progress
756.39400.43343.47202.1395.75
Source: S&P Global Market Intelligence. Standard template. Financial Sources.